Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01801241 · ClinicalTrials.gov registry record · NA

Comparison of Glenoid Component Position Using Intelligent Reusable Instrument (IRI) vs Standard Surgical Instruments

A NA study of Anatomic Total Shoulder Arthroplasty, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT01801241: Completed NA study of Anatomic Total Shoulder Arthroplasty, sponsored by The Cleveland Clinic.

NCT01801241 is a NA study of Anatomic Total Shoulder Arthroplasty that has completed, run by The Cleveland Clinic. The registered enrollment target is 56 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01801241, a NA study of Anatomic Total Shoulder Arthroplasty, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

The proposed clinical study will enroll patients indicated for standard of care anatomic total shoulder arthroplasty. They will receive all pre operative testing, intra-operative care including all implants and post operative care that is standard of care and specific to the surgeon and patients decisions for care. The only difference between the study groups will be the type of surgical instruments used to place the glenoid guide pin. In all cases the surgeon is able and allowed to use their own surgical judgment to place the guide pin, prepare the bone and place the desired implant. In cases that are randomized to the IRIS group the surgeon can use any and all of the standard instruments or guides provided by the implant manufacturer as the surgeon would use in the group of patients randomized to the standard surgical group. If the surgeon chooses not to use the IRIS instruments then this would be noted as a deviation in plan, the reasons recorded and the patient would be excluded from the study without post operative imaging and there pre - operative and intra - operative data would be analyzed for the purpose of understanding the reasons for failure of the IRIS technology to provide surgical assistance for guide pin placement. For patients included in the post operative data analysis will a study specific shoulder CT scan prior to discharge from the hospital to assess the position of the implant. Deviation in the location and position of the implant as compared plan will be our primary outcome measure. Investigators will compare difference between technologies, differences within and between surgeons and the influence of the severity of the pre operative pathology on the two methods of surgical care.

Primary Outcome

The overall difference in component placement between standard of care instrumentation and intelligent reusable instrumentation will be compared (Inclination and Version). Inclination: the angle measurement of the position of the glenoid surface or glenoid implant in the superior-inferior direction. Version: the angle measurement of the position of the glenoid surface or glenoid implant in the anterior-posterior direction.

Interventions

  • DEVICE Anatomic TSA using IRI Instrumentation
  • PROCEDURE Anatomic Total Shoulder Arthroplasty

Study Locations (1)

Ohio

  • Cleveland Clinic Orthopaedic and Rheumatologic Institute - Cleveland

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2013-01
Est. Completion 2013-12
Phase NA
The Cleveland Clinic

688 total trials

What the finished NCT01801241 record still lists

NCT01801241 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Anatomic Total Shoulder Arthroplasty appearing as the primary indexed condition, and to 2 interventions - of which Anatomic TSA using IRI Instrumentation is the first listed.

NCT01801241 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT01801241 about?

NCT01801241 is a clinical study titled "Comparison of Glenoid Component Position Using Intelligent Reusable Instrument (IRI) vs Standard Surgical Instruments". The proposed clinical study will enroll patients indicated for standard of care anatomic total shoulder arthroplasty. They will receive all pre operative testing, intra-operative care including all implants and post operative care that is standard of care and specific to the surgeon and patients dec...

What is the current status of trial NCT01801241?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2013-01. Estimated completion is 2013-12.

What conditions does trial NCT01801241 study?

This clinical trial studies the following conditions: Anatomic Total Shoulder Arthroplasty.

What interventions are being tested in trial NCT01801241?

The interventions under investigation include: Anatomic TSA using IRI Instrumentation (DEVICE), Anatomic Total Shoulder Arthroplasty (PROCEDURE).

Who is sponsoring clinical trial NCT01801241?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01801241 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anatomic Total Shoulder Arthroplasty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01801241's enrollment target sits among peer trials

56 1262nd of 2000 higher than 737 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01801241, the US trial registry maintained by the National Library of Medicine. NCT01801241 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.